A significant relationship between the severity of allergic rhinitis and various allergic inflammatory markers was found but could account for only a minor part of the variation in the patients' evaluation of their disease.
To investigate whether eosinophils are stimulated in
vivo or have acquired an increased susceptibility to stimuli
from the coagulation cascade, the release of eosinophil proteins was
compared for three groups of donors with different levels of serum
IgE. (1) with atopic dermatitis (s-IgE > 5000 IU/ml, n = 11);
(2) with inhalant allergy (200 < s-IgE < 2 000 IU/ml,
n = 10); and (3) non-allergic (s- IgE < 100 IU/ml, n = 10). The
levels of eosinophil cationic protein and eosinophil protein X (ECP,
EPX) were determined in serum (clotting time = 2.0 h) and plasma.
Serum and plasma ECP in normal donors demonstrated large
intra-personal variations (C.V. 50–80%), but serum-ECP
(mean 8.1 ng/ml) was clearly distinguishable from plasma ECP
(mean 1.0 ng/ml) by a factor of 8 (range: 5.6–11.6). The
ECP released during clotting was markedly increased in the atopic
dermatitis group (serum:plasma ratio 13.5, p < 0.003) compared with the other groups (6.7 and 5.6). EPX, having a higher plasma
level, demonstrated a less pronounced release (serum: plasma ratios
2.0, 1.7 and 1.4), with no statistical difference between donor
groups. Considering all donors together the levels of ECP and EPX in
plasma and in serum were correlated to the number of eosinophils
(coefficients of correlation 0.54-0.58, p < 0.002).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.